ALLEGAN, MI (WHTC) - The bottom line continues to be in black ink at Perrigo, with this morning’s quarterly and annual earnings statement written in darker shades than ever before. It was another three months of record sales and revenues for the Allegan-based generic drug maker, with an 18 percent jump in sales to approximately 832 million dollars, and a jump of 26 million in earnings to 121 million, with per-share income up 20 cents to $1.28. For the year, Perrigo had 3.17 billion in sales, good for 469 million in revenue, and a per-share payout of $4.99. It’s the sixth straight year of record sales and earnings, with company officials looking forward to more.